Executive case study, AI sales transformation
How a Top-20 Global Pharmaceutical Company moved field-force decisions from static territory lists to causal, real-time HCP prioritisation.
A top-20 global pharmaceutical company with a significant Emerging Markets commercial footprint, dozens of brands, multiple field forces, and a large HCP universe spread across multiple EM countries.
CommercialAt this scale, small improvements in field-force prioritisation and commercial decision-making translate directly into top-line share and revenue outcomes, making Sales Force Effectiveness (SFE) a board-level priority, not just a field operations concern.
CommercialPartnered with DecisionX, an AI decision-infrastructure company for CPG & Pharma, trusted for 10,000+ monthly enterprise decisions.
Where the platform is live
Analytics, Business & CoE teams engaged on Margin RCA, Sales Excellence, and HCP Intelligence, all validated.
Part of the multi-country EM footprint the platform now extends into, on the same shared infrastructure.
Commercial use cases run on the same infrastructure already proven on the marketing side of the business.
How We Engaged
Multi-stakeholder, consultative model from day one: Data & Analytics, the India Business Team, and CoE each had different definitions of value.
Co-build and iterative feedback loops: commercial and analytics stakeholders validated opportunity-scoring and HCP-prioritisation logic before it reached the field.
End users made stakeholders in the co-building process itself, a deliberate choice to drive adoption, not mandate it.
Trust built methodically: validation, explainable and traceable answers, and feedback loops, non-negotiable where "the AI said so" never satisfies a field manager or compliance officer.
A forward-looking opportunity identifier that drills from Brand–SKU down through Geography to product-level metrics, benchmarked against Plan, Competition, Last Year, and internal best-in-class performance.
Underperforming, high opportunity, focus here first.
In line, moderate opportunity, monitor & improve.
Outperforming, low opportunity, maintain & scale.
Sub-Functional Ontologies Underneath
TRx/NRx, market share, brand performance by territory/SKU vs. Plan, Competition, Last Year.
Pricing, discounting, mix, and cost modelled as a margin waterfall by SKU and geography.
Competitor volumes, pricing moves, share shifts, sizing the opportunity gap, not just the results gap.
Consistent roll-up/drill-down from national to regional to territory level.
Depth and Breadth, Two Different Adoption Stories
Active querying proves trust in the reasoning tool. Signal distribution at 6,000+ users proves the platform scales insight to an entire field force without training every user to query it directly.
Commercial leaders act on RCA and HCP recommendations without a data science briefing. Explainability and traceability were built in from day one, essential for adoption in a compliance-sensitive commercial function.
Data + Domain + Process + Decision layers modelled as one connected graph.
Answers "why," not just "what," a causal state graph, not keyword matching.
Compounds intelligence from past decisions automatically, no manual retraining.
Business teams build and maintain their own ontology, not locked to a vendor.
Orchestrated agents investigate in parallel, then synthesise one answer.
PDFs, decks, scans, emails, DB exports, and roughly 20 languages.
Because the ontology and causal layer are shared infrastructure, this same platform is also the foundation for the company's parallel AI Marketing Transformation work. See our companion case study on media planning and digital optimisation.
Questions, answered
The essentials on scope, validation, data, and time to first value.
Decision Infrastructure for Pharma, CPG and Manufacturing
See DecisionX on your data, your context, your decisions. First value in 15 days.